Spontaneous Retroperitoneal Haemorrhage From Bilateral Renal Angiomyolipomas: A Case Report on a First Presentation of Tuberous Sclerosis Complex

双侧肾血管平滑肌脂肪瘤引起的自发性腹膜后出血:结节性硬化症首发病例报告

阅读:1

Abstract

Renal angiomyolipomas (AMLs) are benign mesenchymal tumours that may present with life-threatening haemorrhages when associated with underlying genetic conditions. AMLs are comprised of mature but disorganised vasculature, smooth muscle and fatty adipose tissue. Whilst the majority of intrarenal AMLs are sporadic and found incidentally as solitary lesions, there is a significant association with tuberous sclerosis complex (TSC). TSC results in the disruption of the mTOR pathway, leading to unregulated cell proliferation and subsequent benign tumour growth. Consequently, AMLs present in TSC are typically large, multiple and complex in nature. In this case, we report a 22-year-old woman with no significant past medical history, who presented with right‑sided abdominal pain and was initially investigated for cholecystitis. Imaging revealed bilateral renal AMLs, a right renal artery pseudoaneurysm and acute retroperitoneal haemorrhage. The patient was stabilised with a transfusion and proceeded to undergo emergency super‑selective embolisation. Physical examination and radiological clues raised further suspicion of TSC. Follow-up interval imaging revealed a 9 mm intra-tumoral aneurysm in the contralateral kidney, which was prophylactically embolised, and neuroimaging revealed subependymal nodules. Subsequent treatment is anticipated to involve pharmaceutical mTOR inhibition, definitive neurological assessment and follow-up at the regional Genetics Centre. In patients with complex AMLs and clues of genetic disease, evaluation for TSC should be prompt. The presence of secondary features should raise suspicion and initiate assessment of underlying genetic conditions in young patients. Evaluation may then unmask serious complications, such as haemorrhage, and early recognition enables targeted intervention, surveillance and holistic patient counselling.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。